Advertisement
Home!
advanced
 
 
sales leads



 
 

Alec Piplani


Bioabsorbable Therapeutics
COO/VP R/D

Email: Not Available
Phone:  Free Trial
City/ST: MenloPark, CA
 
 
 


  Other Executives:  Scott Johnson  David Cappellucci  Roy Camblin  Randy Knapp  Tim Villanueva  James Brailean  Rich Tarrant  Steve Valenzuela
 

Other Bioabsorbable Therapeutics, Inc Emails

 Free Trial


Description: Alec Piplani is Bioabsorbable Therapeutics COO/VP R/D. With a Lead411 subscription, Bioabsorbable Therapeutics email addresses ( @bioabsorbabletx.com ) of the executives are viewable. Other information includes Alec Piplani email, phone, and extension. Be sure to check our Linkedin tab on the company page. Typical management titles include VP, Chief, Vice President, Director, manager, & more. Similar names to Piplani can be found at Executive Directory - Piplani.

Add Alec Piplani Information

Site Reference: http://www.bioabsorbabletx.com/management.html

Alec Piplani — COO and Vice-President of R&D Mr. Piplani has served as COO and Vice-President of R&D since 2006. He has over 18 years of experience developing medical products in a start-up environment. He previously served as COO of Chestnut Medical, Vice President of R&D and COO for Smart Therapeutics, Vice President of R&D for Cardiovention, and Director of Product Development for Endovascular Technologies. Mr. Piplani is a Co-Founder of both KFX Medical Corporation and Chestnut Medical Technologies. He has made several successful "angel investor" placements including Ovion Inc. (acquired by American Medical Systems, Inc.), Vascular FX LLC (acquired by Micrus Endovascular Corporation), and CryoVascular Systems (acquired by Boston Scientific Corporation). Mr. Piplani holds a B.S. in Chemical Engineering and a B.A. in Physics from Rutgers University. He is the author of over 40 patents. Maurice Buchbinder, M.D. — Chief Medical Officer Dr. Buchbinder has served


Copyright 2010 Lead411 | Santa Barbara, CA
© Copyright 2010 Lead411. All Rights Reserved.
Add Company|Companies|Executives|Contact|Terms



Advertisement